Second quarter 2026
Filed Aug 12, 2026Strategic Transformation Delivers Accelerated Profitability Raises Full-Year Adjusted Operating Income and Tightens Adjusted Comparable Store Sales Growth Outlook
Net revenue increased 2.5% to $498.8 million while Adjusted Operating Income increased 32.7% to $31.6 million, supported by higher average ticket, managed care strength, lower SG&A and a favorable net change in margin on unearned revenue. The company raised its Adjusted Operating Income outlook, although it tightened its Adjusted Comparable Store Sales Growth and net revenue ranges and cited lower self-pay customer traffic.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net revenueGAAP | $498.8 million | – | increased 2.5% |
| Comparable store sales growthother | 3.4% | – | – |
| Adjusted Comparable Store Sales Growthnon-GAAP | 2.2% | – | – |
| Store countother | 1,281 stores | – | grew 3.3% |
| Costs applicable to revenueGAAP | $208.4 million | – | increased 4.0% |
| Costs applicable to revenue as a percentage of net revenueGAAP | 41.8% | – | increased 60 basis points |
| Selling, general and administrative expenses (SG&A)GAAP | $243.4 million | – | decreased 1.5% |
| SG&A as a percentage of net revenueGAAP | 48.8% | – | decreased 200 basis points |
| Adjusted SG&Anon-GAAP | $236.2 million | – | decreased 1.6% |
| Adjusted SG&A as a percentage of net revenuenon-GAAP | 47.3% | – | a decrease of 200 basis points |
| Net incomeGAAP | $12.4 million | – | increased |
| Net income marginGAAP | 2.5% | – | improved |
| Diluted earnings per share (EPS)GAAP | $0.15 | – | increased |
| Adjusted Diluted EPSnon-GAAP | $0.25 | – | increased |
| Adjusted Operating Incomenon-GAAP | $31.6 million | – | increased 32.7% |
| Adjusted Operating Marginnon-GAAP | 6.3% | – | improved 140 basis points |
| Year-to-date net revenueGAAP | $1,042.7 million | – | increased 4.6% |
| Year-to-date Comparable store sales growthother | 3.9% | – | – |
| Year-to-date Adjusted Comparable Store Sales Growthnon-GAAP | 3.4% | – | – |
| Year-to-date net incomeGAAP | $43.6 million | – | increased |
| Year-to-date net income marginGAAP | 4.2% | – | increased |
| Year-to-date Diluted EPSGAAP | $0.54 | – | increased |
| Year-to-date Adjusted Diluted EPSnon-GAAP | $0.71 | – | increased |
| Year-to-date Adjusted Operating Incomenon-GAAP | $87.0 million | – | increased 33.7% |
| Year-to-date Adjusted Operating Marginnon-GAAP | 8.3% | – | increased |
Fiscal 2026 outlook for the 52 weeks ending January 2, 2027 outlook
- Revenue$2.037 billion - $2.076 billion
- Tax rate~30%
- NoteNew Stores: 30-35
- NoteAdjusted Comparable Store Sales Growth: 3.0% - 5.0%
- NoteAdjusted Operating Income: $119 million - $139 million
- NoteAdjusted Diluted EPS: $0.94 - $1.09
- NoteDepreciation and Amortization: $92 million - $93 million
- NoteInterest: $11 million - $13 million
- NoteCapital Expenditures: $72 million - $76 million
- NoteAdjusted Diluted EPS assumes approximately 81 million shares.
- NoteDepreciation and Amortization includes amortization of acquisition intangibles of approximately $0.7 million.
- NoteInterest is before the impact of gains or losses on change in fair value of derivatives and charges related to debt discounts and deferred financing costs.
Capital returns
- During the three months ended July 4, 2026, the Company repurchased approximately 1.2 million shares for $20.0 million.
- As of July 4, 2026, the share repurchase authorization has remaining capacity of $30.0 million.
What drove it
- Net revenue growth was driven by new store sales, a positive 0.8% impact from the timing of unearned revenue and Adjusted Comparable Store Sales Growth, partially offset by closed stores.
- Comparable store sales growth reflected higher average ticket and continued strength in the managed care cohort.
- SG&A declined primarily because of lower associate-related expenses, including variable incentive compensation, and lower advertising expense.
- The company completed its website replatform, which management described as a unified commerce foundation to connect the exam, prescription and retail journey at scale.
- Management cited new brand introductions, store segmentation and increased back-half marketing investment as initiatives gaining traction.
Concerns
- Lower self-pay customer traffic partially offset higher average ticket and continued strength in the managed care cohort.
- Costs applicable to revenue increased 4.0% to $208.4 million and increased 60 basis points as a percentage of net revenue, reflecting a strategic mix shift toward higher-value product offerings.
- Higher occupancy expense partially offset lower associate-related expenses and lower advertising expense within SG&A.
- The company tightened its fiscal 2026 Adjusted Comparable Store Sales Growth outlook to 3.0% - 5.0% from 3.0% - 6.0% and its net revenue outlook to $2.037 billion - $2.076 billion from $2.033 billion - $2.091 billion.
- The outlook identifies dynamic market conditions, tariffs, transformation-initiative implementation issues, geopolitical issues, higher transportation or other costs due to rising fuel or energy costs, and other macroeconomic risks and uncertainties.
What to watch
- Whether higher average ticket and managed care cohort strength continue to offset lower self-pay customer traffic.
- The impact of increased back-half marketing investment on Adjusted Comparable Store Sales Growth.
- Execution of new brand introductions, store segmentation and the completed website replatform.
- Delivery against fiscal 2026 Adjusted Operating Income guidance of $119 million - $139 million.
- Store openings against the fiscal 2026 target of 30-35 new stores.
Balance sheet and cash flow
- National Vision’s cash balance was $36.0 million as of July 4, 2026.
- The Company had no borrowings outstanding under its $300.0 million first lien revolving credit facility, exclusive of letters of credit of $6.7 million.
- Total debt was $237.7 million as of July 4, 2026, consisting of outstanding first lien term loans and finance lease obligations, net of unamortized discounts.
Analysis
National Vision reported a profitable second-quarter improvement despite modest top-line growth. Net revenue increased 2.5% to $498.8 million, while comparable store sales growth was 3.4% and Adjusted Comparable Store Sales Growth was 2.2%. Revenue benefited from new store sales, a positive 0.8% impact from the timing of unearned revenue and comparable-store growth, partly offset by closed stores. Store count ended at 1,281 stores after nine America’s Best openings and two America’s Best closures during the quarter.
The sales mix and customer mix were central to the result. Higher average ticket and continued strength in the managed care cohort supported comparable-store growth, while lower self-pay customer traffic was a counterweight. Management characterized its strategy as an intentional shift toward a healthier customer base and higher-value transactions. The company also said deferred purchases among its least profitable, lower-value transactions were more than offset by these initiatives.
Profitability grew substantially faster than revenue. Adjusted Operating Income increased 32.7% to $31.6 million and Adjusted Operating Margin improved to 6.3% from 4.9%. GAAP net income rose to $12.4 million from $8.7 million, and Diluted EPS increased to $0.15 from $0.11. Lower associate-related expenses and advertising expense reduced SG&A, although higher occupancy expense was a partial offset. Costs applicable to revenue rose 4.0% to $208.4 million and increased 60 basis points to 41.8% of revenue, which the company attributed to the strategic mix shift toward higher-value product offerings. The net change in margin on unearned revenue benefited net income by $2.2 million and Adjusted Operating Income by $2.9 million.
Year-to-date trends also show operating leverage. Net revenue increased 4.6% to $1,042.7 million, while year-to-date Adjusted Operating Income increased 33.7% to $87.0 million and Adjusted Operating Margin increased to 8.3% from 6.5%. The company also repurchased approximately 1.2 million shares for $20.0 million during the quarter, ending with $30.0 million of remaining authorization capacity. Cash was $36.0 million and total debt was $237.7 million as of July 4, 2026.
The fiscal 2026 guide raises the Adjusted Operating Income range to $119 million - $139 million from $107 million - $133 million and raises the lower end of Adjusted Diluted EPS to $0.94 from $0.85 while retaining the $1.09 upper end. At the same time, the company narrowed Adjusted Comparable Store Sales Growth to 3.0% - 5.0% and tightened net revenue to $2.037 billion - $2.076 billion. The key operating questions are whether ticket growth and managed care demand can continue to counter lower self-pay traffic, and whether back-half marketing investment, new brand introductions, store segmentation and the completed website replatform translate into the guided full-year outcome.
Management, verbatim
We delivered stronger profitability as higher-value transactions, managed care customers and ticket growth gained momentum.
Alex Wilkes, National Vision’s CEO
We believe these actions are building a more durable business, and are more than offsetting deferred purchases among our least profitable, lower-value transactions.
Alex Wilkes, National Vision’s CEO
With these initiatives gaining traction, we are raising our adjusted operating income guidance as we continue to drive profitable growth.
Alex Wilkes, National Vision’s CEO
Not in the filing
stated, not guessed- GAAP gross profit and gross margin
- GAAP operating income and operating margin
- Segment revenue and segment profitability
- Operating cash flow
- Free cash flow
- Cash flow from investing activities
- Cash flow from financing activities
- Dividend information
- Quarter-over-quarter comparisons for reported second-quarter metrics
- Prior-year values for net revenue, costs applicable to revenue, SG&A, Adjusted SG&A, Adjusted Operating Income and year-to-date Adjusted Operating Income
- A separately provided previous quarterly-release outlook for formal comparison of actual fiscal 2026 results versus prior guidance
- CFO commentary
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.